LeadIQ logo
Learn more at LeadIQ.com

Insights

Expanding Product Portfolio Shionogi Europe has been actively partnering with companies like CILcare Inc., Akili, and Sage Therapeutics to develop and commercialize innovative medications for various medical needs, such as hearing loss, malaria prevention, and depression treatment. These strategic collaborations indicate opportunities for cross-selling complementary products and expanding the product portfolio to address a wider range of health conditions.

Focus on Emerging Markets With an established presence in major European markets and a track record of successful partnerships, Shionogi Europe is well-positioned to explore sales opportunities in emerging markets. Leveraging its expertise in antimicrobial resistance, HIV, and other therapeutic areas, the company can tap into emerging regions where there is a growing demand for innovative pharmaceutical solutions.

Innovative Pipeline Development Shionogi's commitment to developing medications for unmet medical needs and its focus on novel pharmacologic therapies, such as therapies for obstructive sleep apnea, present significant sales opportunities. By aligning sales strategies with the progression of its innovative pipeline, Shionogi Europe can secure competitive advantages in the market and cater to evolving healthcare demands.

Strategic Acquisitions and Partnerships The company's proactive approach to strategic acquisitions, as seen with the acquisition of Tetra and partnerships with renowned institutions like Nagasaki University and Apnimed, indicates a strong focus on expanding market reach and leveraging expertise across different areas. These collaborations offer avenues for sales teams to explore new customer segments and enhance revenue streams.

Regulatory Expertise and Leadership Recruitment of key personnel such as Ramón Polo as Senior Vice President, Head of Regulatory Affairs, showcases Shionogi Europe's emphasis on regulatory compliance and leadership in navigating complex regulatory landscapes. Sales teams can leverage the company's regulatory expertise to build trust with customers, address compliance concerns, and expedite sales cycles.

Similar companies to Shionogi Europe

Shionogi Europe Tech Stack

Shionogi Europe uses 8 technology products and services including SAS Viya, WordPress, PHP, and more. Explore Shionogi Europe's tech stack below.

  • SAS Viya
    Advanced Analytics And Data Science
  • WordPress
    Content Management System
  • PHP
    Programming Languages
  • C#
    Programming Languages
  • Python
    Programming Languages
  • New Relic
    Real User Monitoring
  • Google Tag Manager
    Tag Management
  • IIS
    Web Servers

Media & News

Shionogi Europe's Email Address Formats

Shionogi Europe uses at least 2 format(s):
Shionogi Europe Email FormatsExamplePercentage
First.Last@shionogi.euJohn.Doe@shionogi.eu
90%
First.Middle.Last@shionogi.euJohn.Michael.Doe@shionogi.eu
3%
First.Middle@shionogi.euJohn.Michael@shionogi.eu
2%
F.Last@shionogi.euJ.Doe@shionogi.eu
2%
First.MiddleLast@shionogi.euJohn.MichaelDoe@shionogi.eu
2%
Last@shionogi.euDoe@shionogi.eu
1%
First.Last@shionogi.comJohn.Doe@shionogi.com
65%
FLast@shionogi.comJDoe@shionogi.com
33%
FirstLast@shionogi.comJohnDoe@shionogi.com
1%
First.Middle@shionogi.comJohn.Michael@shionogi.com
1%

Frequently Asked Questions

Where is Shionogi Europe's headquarters located?

Minus sign iconPlus sign icon
Shionogi Europe's main headquarters is located at Herengracht 464 Amsterdam, North Holland 1017 BZ NL. The company has employees across 4 continents, including EuropeAsiaOceania.

What is Shionogi Europe's phone number?

Minus sign iconPlus sign icon
You can contact Shionogi Europe's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Shionogi Europe's official website and social media links?

Minus sign iconPlus sign icon
Shionogi Europe's official website is shionogi.com and has social profiles on LinkedIn.

How much revenue does Shionogi Europe generate?

Minus sign iconPlus sign icon
As of August 2024, Shionogi Europe's annual revenue reached $75M.

What is Shionogi Europe's NAICS code?

Minus sign iconPlus sign icon
Shionogi Europe's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Shionogi Europe have currently?

Minus sign iconPlus sign icon
As of August 2024, Shionogi Europe has approximately 276 employees across 4 continents, including EuropeAsiaOceania. Key team members include Vice President Strategy Business Development: A. S.Vice President Clinical Operations: Y. M.Head Of Clinical Operations: V. T.. Explore Shionogi Europe's employee directory with LeadIQ.

What industry does Shionogi Europe belong to?

Minus sign iconPlus sign icon
Shionogi Europe operates in the Pharmaceutical Manufacturing industry.

What technology does Shionogi Europe use?

Minus sign iconPlus sign icon
Shionogi Europe's tech stack includes SAS ViyaWordPressPHPC#PythonNew RelicGoogle Tag ManagerIIS.

What is Shionogi Europe's email format?

Minus sign iconPlus sign icon
Shionogi Europe's email format typically follows the pattern of . Find more Shionogi Europe email formats with LeadIQ.

When was Shionogi Europe founded?

Minus sign iconPlus sign icon
Shionogi Europe was founded in 2012.
Shionogi Europe

Shionogi Europe

Pharmaceutical ManufacturingNorth Holland, Netherlands201-500 Employees

Shionogi B.V. (known as “Shionogi Europe”) is the European headquarters of Shionogi & Co., Ltd, a leading global research-driven pharmaceutical company based in Osaka, Japan. Since 1878, Shionogi has been striving to supply the best possible medicines to protect the health and wellbeing of the patients we serve. 

We are dedicated to finding innovative solutions for pressing unmet clinical needs, and have a strong track record in discovering and developing novel medicines for antimicrobial resistance (AMR), HIV and influenza. Alongside our work in infectious diseases, we also have extensive expertise in other areas of unmet clinical needs within our Hospital Specialty Business, and a strong track record in other therapy areas affecting quality of life, particularly Women’s Health.

Since launching in Europe in 2012, we have significantly expanded our presence and now have coverage of the biggest markets in the continent. Our offices in Amsterdam, Berlin, London, Madrid, Paris and Rome provide the bases for over 300 passionate staff from across the spectrum of big pharma and biotech, as well as experts in technology, creatives, entrepreneurs and others - who come together to do things differently and better.

Our culture is unique, blending our Japanese roots with our strong and rapidly growing European operation. We have a friendly, inclusive work environment and aim to foster a culture that encourages our people to break out of the boundaries of the traditional pharmaceutical company. 

Through successful strategic partnerships and open collaboration, we are determined to shape the future of healthcare. Our ambitious growth plans include extending the reach of our marketed products, developing our innovative pipeline of medicines and securing the right partnerships and acquisitions to accelerate our development. 

To find out about partnering with us, visit: https://t.ly/YzlSu 

For career opportunities, visit: https://t.ly/mERcQ 

NP-EU-NP-0303 DOP July 2024 

Section iconCompany Overview

Headquarters
Herengracht 464 Amsterdam, North Holland 1017 BZ NL
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
201-500

Section iconFunding & Financials

  • $50M$100M

    Shionogi Europe's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Shionogi Europe's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.